Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 7 No. 7, July 2006
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Covey, M. V.
Right arrow Articles by Levison, S. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Covey, M. V.
Right arrow Articles by Levison, S. W.

NeoReviews Vol.7 No.7 2006 e353
© 2006 American Academy of Pediatrics

Pathophysiology of Perinatal Hypoxia-Ischemia and the Prospects for Repair from Endogenous and Exogenous Stem Cells

Matthew V. Covey, PhD*
Steven W. Levison, PhD*

* Laboratory for Regenerative Neurobiology, Department of Neurology and Neurosciences, UMDNJ-New Jersey Medical School, Newark, NJ

Abbreviations: AMPA alpha-3-hydroxy-5-methyl-isoxazole • BrdU bromodeoxyuridine • Dcx doublecortin • EAA excitatory amino acid • GFAP glial fibrillary acidic protein • H/I hypoxia-ischemia • NeuN neuronal nuclei • NMDA N-methyl-D-aspartate • NSP neural stem/progenitors • PSA-NCAM polysialic acid-neural cell adhesion molecule • SDF-1-alpha stromal cell-derived factor-1-alpha • SGZ subgranular zone • SVZ subventricular zone • VZ ventricular zone

The first 300 words of the full text of this article appear below.


    Learning Objectives
 
After completing this article, readers should be able to:

  1. Compare the pathophysiology of hypoxia-ischemia (H/I) in preterm and term infants.
  2. Delineate the differing effects of H/I on cells involved in development in the subventricular zone of the brain.
  3. Describe the prospects for neural repair of neurons, oligodendrocytes, and projection neurons.
  4. List the infants who are most likely to benefit from stem cell therapy to repair the brain.


    Introduction
 
Perinatal hypoxia-ischemia (H/I) refers to exposure to low oxygen (hypoxia) and decreased blood flow (ischemia) prior to, during, or after birth and is regarded as a dominant cause of neurologic deficits in term and preterm infants. Numerous reviews have summarized the pathophysiology and histopathology of such insults and reviewed neuroprotective strategies. However, with accumulating evidence that many of these insults occur in utero, prevention may prove difficult, demanding that regenerative strategies be pursued to reduce the morbidity associated with the events. Therefore, in this review, we discuss the potential roles of endogenous and exogenous neural stem cells and progenitors in repairing the infant brain.


    Incidence and Pathophysiology of Perinatal H/I
 
Perinatal H/I is an important clinical issue for both preterm and term infants. Approximately 55% of insults occur prior to or during birth as a result of underlying complications manifested prior to birth. (1) Despite major advances in obstetric care and management, the incidence of cerebral palsy, which has been associated with H/I, has remained at approximately 2 per 1,000 live births. (2)(3)(4) With advances in newborn intensive care, 80% of babies born extremely prematurely, during the second trimester, now survive, (5) but they often experience repeated hypoxic episodes. They have a 7% chance of developing cerebral palsy (5) and a 50% chance of developing motor, cognitive, and behavioral disorders. (6) A number of factors . . . [Full Text of this Article]







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Academy of Pediatrics.